Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Bicycle Therapeutics PLC
SWB:50BA
Bicycle Therapeutics PLC
SWB:50BA
Price:
3.58
EUR
5.29%
Market Closed
Market Cap:
€243.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bicycle Therapeutics PLC
SWB:50BA
|
UK |
|
C
|
Commerzbank AG
XHAM:CBK
|
DE |
|
B
|
Bridgestone Corp
OTC:BRDCF
|
JP |
|
F
|
Freeport-McMoRan Inc
DUS:FPMB
|
US |
|
L
|
Launch One Acquisition Corp
NASDAQ:LPAA
|
US |
|
D
|
DataDot Technology Ltd
ASX:DDT
|
AU |
Wall St Price Targets
50BA Price Forecast
Based on 9 analysts
Based on 9 analysts
+177% Upside
from
€3.58
today
Bicycle Therapeutics PLC (50BA)’s 12-month stock price forecast through August 2027 has a consensus target of €9.92, implying 177% upside. The forecast is based on price targets from 9 Wall Street analysts.
50BA Analyst Rating
No ratings yet
No ratings yet
Bicycle Therapeutics PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 50BA's stock price target?
Price Target
9.92
EUR
9.92
EUR
According to Wall Street analysts, the average 1-year price target for 50BA is 9.92 EUR with a low forecast of 4.46 EUR and a high forecast of 13 EUR.
What is the Revenue forecast for Bicycle Therapeutics PLC?
Projected CAGR
30%
30%
Over the last 8 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 8 years is 30%.